82_FR_12663 82 FR 12621 - National Center for Complementary & Integrative Health; Notice of Closed Meeting

82 FR 12621 - National Center for Complementary & Integrative Health; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 42 (March 6, 2017)

Page Range12621-12622
FR Document2017-04176

Federal Register, Volume 82 Issue 42 (Monday, March 6, 2017) 
[Federal Register Volume 82, Number 42 (Monday, March 6, 2017)]
[Notices]
[Pages 12621-12622]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-04176]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Integrative Health; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Integrative Health Special Emphasis Panel, Exploratory Clinical 
Trials and Studies of Natural Products.
    Date: March 30, 2017.
    Time: 12:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy

[[Page 12622]]

Boulevard, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Yisong Wang, Ph.D., Scientific Review Officer, 
NCCIH/NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20817, 301-
480-9483, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.213, 
Research and Training in Complementary and Integrative Health, 
National Institutes of Health, HHS)

    Dated: February 28, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04176 Filed 3-3-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 42 / Monday, March 6, 2017 / Notices 12621 CTSU AND NCI CIRB FORMS AND CTSU, CIRB AND CTEP SURVEYS—ESTIMATED ANNUALIZED BURDEN HOURS— Continued Average Number of Type of Number of burden per Total annual Form name responses per respondent respondents response burden hours respondent (in hours) Reviewer Worksheet Expedited Study Clo- Board Members .................... 20 1 15/60 5 sure Review (Attachment B36). Reviewer Worksheet Expedited Review of Board Members .................... 5 1 30/60 3 Study Chair Response to CIRB-Required Modifications (Attachment B37). Reviewer Worksheet of Expedited IR (At- Board Members .................... 5 1 30/60 3 tachment B38). Reviewer Worksheet—CPC—Determination Board Members .................... 40 1 15/60 10 of UP or SCN (Attachment B39). Annual Signatory Institution Worksheet Health Care Practitioner ....... 400 1 40/60 267 About Local Context (Attachment B40). Annual Principal Investigator Worksheet Health Care Practitioner ....... 1800 1 20/60 600 About Local Context (Attachment B41). Study-Specific Worksheet About Local Con- Health Care Practitioner ....... 4800 1 20/60 1600 text (Attachment B42). Study Closure or Transfer of Study Review Health Care Practitioner ....... 1680 1 15/60 420 Responsibility Form (Attachment B43). UP or SCN Reporting Form (Attachment Health Care Practitioner ....... 360 1 20/60 120 B44). Change of SI PI Form (Attachment B45) ..... Health Care Practitioner ....... 120 1 15/60 30 CTSU Website Customer Satisfaction Sur- Health Care Practitioner ....... 275 1 15/60 69 vey (Attachment C1). CTSU Help Desk Customer Satisfaction Health Care Practitioner ....... 325 1 15/60 81 Survey (Attachment C2). CTSU OPEN Survey (Attachment C3) ......... Health Care Practitioner ....... 60 1 15/60 15 CIRB Customer Satisfaction Survey (Attach- Participants ........................... 600 1 15/60 150 ment C4) Satisfaction Survey (Attachment C4). Follow-up Survey (Communication Audit) Participants/Board Members 300 1 15/60 75 (Attachment C5). Website Focus Groups, Communication Participants/Board Members 18 1 1 18 Project (Attachment C6 A–D). CIRB Board Member Annual Assessment Board Members .................... 60 1 20/60 20 Survey (Attachment C7). PIO Customer Satisfaction Survey (Attach- Health Care Practitioner ....... 60 1 5/60 5 ment C8). Concept Clinical Trial Survey (Attachment Health Care Practitioner ....... 500 1 5/60 42 C9). Prospective Clinical Trial Survey (Attach- Health Care Practitioner ....... 1000 1 1/60 17 ment C10). Low Accrual Clinical Trial Survey (Attach- Health Care Practitioner ....... 1000 1 1/60 17 ment C11). ETCTN PI Survey (Attachment 12) .............. Physician .............................. 75 1 15/60 19 ETCTN RS Survey (Attachment 13) ............ Health Care Practitioner ....... 175 1 15/60 44 Totals ..................................................... ............................................... 24,100 100,337 ........................ 15,525 Dated: February 15, 2017. DEPARTMENT OF HEALTH AND the discussions could disclose Karla Bailey, HUMAN SERVICES confidential trade secrets or commercial PRA OMB Liaison, Office of Management property such as patentable material, Policy and Compliance, National Cancer National Institutes of Health and personal information concerning Institute (NCI) National Institutes of Health individuals associated with the grant (NIH). National Center for Complementary & applications, the disclosure of which Integrative Health; Notice of Closed would constitute a clearly unwarranted [FR Doc. 2017–04253 Filed 3–3–17; 8:45 am] Meeting invasion of personal privacy. BILLING CODE 4140–01–P Pursuant to section 10(d) of the asabaliauskas on DSK3SPTVN1PROD with NOTICES Name of Committee: National Center for Federal Advisory Committee Act, as Complementary and Integrative Health amended (5 U.S.C. App.), notice is Special Emphasis Panel, Exploratory Clinical hereby given of the following meeting. Trials and Studies of Natural Products. Date: March 30, 2017. The meeting will be closed to the Time: 12:00 p.m. to 4:30 p.m. public in accordance with the Agenda: To review and evaluate grant provisions set forth in sections applications. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: National Institutes of Health, Two as amended. The grant applications and Democracy Plaza, 6707 Democracy VerDate Sep<11>2014 19:24 Mar 03, 2017 Jkt 241001 PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 E:\FR\FM\06MRN1.SGM 06MRN1

12622 Federal Register / Vol. 82, No. 42 / Monday, March 6, 2017 / Notices Boulevard, Bethesda, MD 20892, (Virtual Name of Committee: National Cancer ACTION: Notice of accreditation and Meeting). Institute Special Emphasis Panel, Digital approval of Inspectorate America Contact Person: Yisong Wang, Ph.D., Platforms to Support Informal Cancer Corporation as a commercial gauger and Scientific Review Officer, NCCIH/NIH, 6707 Caregiving. Date: March 30–31, 2017. laboratory. Democracy Blvd., Suite 401, Bethesda, MD 20817, 301–480–9483, yisong.wang@nih.gov. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract SUMMARY: Notice is hereby given, (Catalogue of Federal Domestic Assistance pursuant to CBP regulations, that Program Nos. 93.213, Research and Training proposals. Place: National Cancer Institute Shady Inspectorate America Corporation has in Complementary and Integrative Health, National Institutes of Health, HHS) Grove, 9609 Medical Center Drive, Room been approved to gauge petroleum and 4W032/34, Rockville, MD 20850, (Telephone certain petroleum products and Dated: February 28, 2017. Conference Call). accredited to test petroleum and certain Michelle Trout, Contact Person: Scott A. Chen, Ph.D., petroleum products for customs Scientific Review Officer, Program Program Analyst, Office of Federal Advisory purposes for the next three years as of Committee Policy. Coordination and Referral Branch, Division of Extramural Activities, National Cancer July 21, 2016. [FR Doc. 2017–04176 Filed 3–3–17; 8:45 am] Institute, NIH, 9609 Medical Center Drive, DATES: The accreditation and approval BILLING CODE 4140–01–P Room 7W526, Bethesda, MD 20892–9750, of Inspectorate America Corporation as 240–276–6038, chensc@mail.nih.gov. commercial gauger and laboratory Name of Committee: National Cancer became effective on July 21, 2016. The DEPARTMENT OF HEALTH AND Institute Special Emphasis Panel, Cancer next triennial inspection date will be HUMAN SERVICES Biomarkers and Biospecimens. scheduled for July 2019. Date: March 31, 2017. National Institutes of Health Time: 12:00 p.m. to 4:00 p.m. FOR FURTHER INFORMATION CONTACT: Agenda: To review and evaluate grant Approved Gauger and Accredited National Cancer Institute; Notice of applications. Laboratories Manager, Laboratories and Closed Meetings Place: National Cancer Institute Shady Scientific Services Directorate, U.S. Grove, 9609 Medical Center Drive, Room Customs and Border Protection, 1300 Pursuant to section 10(d) of the 7W106, Rockville, MD 20850, (Telephone Conference Call). Pennsylvania Avenue NW., Suite Federal Advisory Committee Act, as 1500N, Washington, DC 20229, tel. 202– Contact Person: Reed A. Graves, Ph.D., amended (5 U.S.C. App.), notice is Scientific Review Officer, Research 344–1060. hereby given of the following meetings. Technology and Contract Review Branch, SUPPLEMENTARY INFORMATION: Notice is The meetings will be closed to the Division of Extramural Activities, National hereby given pursuant to 19 CFR 151.12 public in accordance with the Cancer Institute, NIH, 9609 Medical Center and 19 CFR 151.13, that Inspectorate provisions set forth in sections Drive, Room 7W106, Rockville, MD 20892– 9750, 240–276–6384, gravesr@mail.nih.gov. America Corporation, 22934 Lockness 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Ave, Torrance, CA 90501 has been as amended. The grant applications/ (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; approved to gauge petroleum and contract proposals and the discussions certain petroleum products and 93.393, Cancer Cause and Prevention could disclose confidential trade secrets Research; 93.394, Cancer Detection and accredited to test petroleum and certain or commercial property such as Diagnosis Research; 93.395, Cancer petroleum products for customs patentable material, and personal Treatment Research; 93.396, Cancer Biology purposes, in accordance with the information concerning individuals Research; 93.397, Cancer Centers Support; provisions of 19 CFR 151.12 and 19 CFR associated with the grant applications/ 93.398, Cancer Research Manpower; 93.399, 151.13. Inspectorate America contract proposals, the disclosure of Cancer Control, National Institutes of Health, Corporation is approved for the which would constitute a clearly HHS) following gauging procedures for unwarranted invasion of personal Dated: February 28, 2017. petroleum and certain petroleum privacy. Melanie J. Pantoja, products from the American Petroleum Name of Committee: National Cancer Program Analyst, Office of Federal Advisory Institute (API): Institute Special Emphasis Panel, Committee Policy. Quantitative Imaging for Evaluation of [FR Doc. 2017–04173 Filed 3–3–17; 8:45 am] API chapters Title Cancer Therapies (U01). BILLING CODE 4140–01–P Date: March 29, 2017. 3 ....................... Tank Gauging. Time: 11:00 a.m. to 5:00 p.m. 7 ....................... Temperature Determination. Agenda: To review and evaluate grant 8 ....................... Sampling. applications. DEPARTMENT OF HOMELAND 12 ..................... Calculations. Place: National Cancer Institute Shady SECURITY 17 ..................... Marine Measurement. Grove, 9609 Medical Center Drive, Room 7W260, Rockville, MD 20850, (Telephone U.S. Customs and Border Protection Inspectorate America Corporation is Conference Call). accredited for the following laboratory Contact Person: Nadeem Khan, Ph.D., Accreditation and Approval of analysis procedures and methods for Scientific Review Officer, Research Inspectorate America Corporation, as a Technology and Contract Review Branch, petroleum and certain petroleum Commercial Gauger and Laboratory Division of Extramural Activities, National products set forth by the U.S. Customs Cancer Institute, NIH, 9609 Medical Center AGENCY: U.S. Customs and Border and Border Protection Laboratory asabaliauskas on DSK3SPTVN1PROD with NOTICES Drive, Room 7W260, Bethesda, MD 20892– Protection, Department of Homeland Methods (CBPL) and American Society 9750, 240–276–5856, nadeem.khan@nih.gov. Security. for Testing and Materials (ASTM): CBPL No. ASTM Title 27–01 .............. D 287 Standard Test Method for API Gravity of Crude Petroleum and Petroleum Products (Hydrometer Method). 27–05 .............. D 4928 Standard Test Method for Water in Crude Oils by Coulometric Karl Fischer Titration. 27–06 .............. D 473 Standard Test Method for Sediment in Crude Oils and Fuel Oils by the Extraction Method. 27–07 .............. D 4807 Standard Test Method for Sediment in Crude Oil by Membrane Filtration. VerDate Sep<11>2014 19:24 Mar 03, 2017 Jkt 241001 PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 E:\FR\FM\06MRN1.SGM 06MRN1


Document Created: 2017-03-04 00:07:03
Document Modified: 2017-03-04 00:07:03
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 30, 2017.
FR Citation82 FR 12621 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR